FDA Inspection
Legacy Health IRBLegacy Health IRB – FDA Inspection, Dec 17, 2021
Record Details
This FDA Inspection record concerns Legacy Health IRB, with an inspection on December 17, 2021, covering biologics.
- Company
- Legacy Health IRB
- Inspection Date
- December 17, 2021
- Product Type
- Biologics
View Company Profile
ID · def26686-2533-4b98-9763-51fe7c679b5b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1159207
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 50.25(a)(8)Participation; refusal and discontinuance
- 21 CFR 50.25(a)(2)Reasonably foreseeable risks or discomforts
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.106(e)Changes in contact or chairperson information
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Legacy Health IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 24, 2026 | Not classified | Seattle District Office | |
| April 3, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Legacy Health IRB
- FDA Inspection 1304792 - 2026-02-24
- FDA Inspection 872380 - 2014-04-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.